在心脏和脏疾病中的阿尔多和阿尔多调节
Francesco Fioretti1, Jeffrey M Testani2, Maria Clarissa Tio3
1Baylor Scott and White Research Institute, Dallas, Texas, USA; Cardiology Unit, ASST Spedali Civili Hospital and University of Brescia, Brescia, Italy.
Journal of the American College of Cardiology
|July 30, 2025
概括
过量的阿尔多素会损害心脏和脏. 矿物质皮质类受体抗剂 (MRA) 有帮助,但残留风险仍然存在,需要进一步研究心脏脏疾病的新疗法.
科学领域:
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學.
- 内分泌学 在内分泌学.
背景情况:
- 慢性激活氨酸-氨酸-氨系统和过量的氨会导致炎症,纤维化和心脏和脏功能障碍.
- 这些有害影响通过基因组和非基因组矿物质皮质体受体 (MR) 途径进行介导.
- 矿物质皮质类受体抗剂 (MRA) 抵消阿尔多斯的作用,但可能会使患者由于高胆固醇和补偿性神经激素激活而处于残留风险.
研究的目的:
- 审查阿尔多在心力衰竭 (HF) 和慢性病 (CKD) 中的作用.
- 讨论类固醇和非类固醇MRA的机制和临床影响.
- 探索新兴的治疗策略,包括部分MR激动剂和阿尔多氨酸合成酶抑制剂.
主要方法:
- 对阿尔多素,MRA和心脏脏疾病研究的文献综述.
- 对阿尔多激素作用机制和MRA效应的分析.
- 综合关于当前和新型治疗方法的证据.
主要成果:
- 阿尔多激素通过MR依赖和独立的途径促进心脏损伤.
- MRAs部分减轻了阿尔多斯特的作用,但并没有消除残留风险.
- 在MRA治疗期间补偿性神经激素激活需要进一步调查临床意义.
结论:
- 阿尔多斯特在HF和CKD的进展中发挥着关键作用.
- 虽然MRA是有益的,但其余风险需要探索替代和辅助疗法.
- 部分MR激动剂和阿尔多合成酶抑制剂代表了管理心脏脏疾病的有希望的未来策略.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
510
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
510
01:33Hormonal Regulation
33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
01:22Heart Failure Drugs: Diuretics
495
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
495
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
773
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
773
01:17Hormonal Regulation of Blood Pressure
3.2K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
3.2K
01:18Hypertension and Regulation of Blood Pressure
3.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K